SCHEMBL21417038

SCHEMBL21417038

NC1(C(NC(=O)c2cc3ccc(F)cc3s2)C2CCCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 12/20 0.50
▸ HTR3A P46098 5/20 0.50
▸ HDAC1 Q13547 2/20 0.40
▸ OPRM1 P35372 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ PIN1 Q13526 1/20 0.38
▸ TACR2 P21452 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20661376 0.91 CHRNA7 (0.50) CHRNA7HTR3AOPRM1PIN1L3MBTL1
SCHEMBL21417015 0.84 CHRNA7 (0.52) CHRNA7HTR3AHDAC1OPRM1HDAC3
SCHEMBL21417016 0.82 CHRNA7 (0.54) CHRNA7HDAC1OPRM1HDAC3HDAC4
SCHEMBL21417023 0.80 CHRNA7 (0.53) CHRNA7HTR3AHDAC1HDAC3HDAC4
SCHEMBL21417305 0.76 HDAC3 (0.59) CHRNA7HTR3AHDAC1HDAC3HDAC4
SCHEMBL21417331 0.75 CHRNA7 (0.52) CHRNA7HTR3AHDAC1OPRM1HDAC3
SCHEMBL21417005 0.74 CHRNA7 (0.55) CHRNA7HTR3A
SCHEMBL21416981 0.73 CHRNA7 (0.54) CHRNA7HTR3AHDAC1OPRM1HDAC3
SCHEMBL21417242 0.72 CHRNA7 (0.47) CHRNA7HTR3A
SCHEMBL21417045 0.72 CHRNA7 (0.47) CHRNA7HTR3AHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233087-B1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS AXOVANT SCIENCES GMBH (DE) 2019-10-02 — — EP disclosed
Send feedback